MedTrace Logo

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

NCT06696534 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-10-02

No results posted yet for this study

Summary

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

* Values of experience of participants into screening programme.
* Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Conditions

  • Screening for Colon Cancer
  • Survey and Questionnaire

Interventions

OTHER

Survey using a questionnaire.

Preference questionnaire for colorectal cancer screening methods

OTHER

Survey using a questionnaire.

Experience questionnaire into colorectal cancer screening programme

Sponsors & Collaborators

  • SERMAS

    collaborator UNKNOWN

  • ULS de Santa Maria

    collaborator UNKNOWN

  • ADVANCED MARKER DISCOVERY S.L.

    lead INDUSTRY

Principal Investigators

  • Maria A Perez, MD · Primary Health Care Centre Mar Báltico

  • Ana Rita, MD · Unidade Local de Saúde de Santa Maria

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-19
Primary Completion
2025-11-30
Completion
2025-12-31

Countries

  • Portugal
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06696534 on ClinicalTrials.gov